| Year | Paper |
|---|---|
| 2007 | Barlow DP, Bartolomei MS. Genomic imprinting in mammals. Chapter 19 in EPIGENETICS Edited by D. Allis, T. Jenuwein D. Reinberg. CSH Press 2007. ISBN 978-087969724–2. Book Chapter. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/24492710 |
| 2007 | Binder CJ, Hartvigsen K, Witztum JL. Promise of immune modulation to inhibit atherogenesis. J Am Coll Cardiol. 2007, 50(6):547–50. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/17678739 |
| 2007 | Bro S, Binder CJ, Witztum JL, Olgaard K, Nielsen LB. Inhibition of the Renin-Angiotensin System Abolishes the Proatherogenic Effect of Uremia in Apolipoprotein E-Deficient Mice. Arterioscl Thromb Vasc Biol. 2007, 27(5):1080–6. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/17347482 |
| 2007 | Colinge J, Bennett KL. Introduction to computational proteomics. PLoS Comput Biol 2007, 3:e114. Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1933459/ |
| 2007 | Colinge J. Peptide fragment intensity statistical modelling. Anal Chem 2007, 79, 7286–7290. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/17713966 |
| 2007 | Dessing M, Knapp S, Florquin S, de Vos AF, van der Poll T. CD14 facilitates invasive respiratory tract infections by Streptococcus pneumoniae. Am J Respir Crit Care Med. 2007, 175:604–611. Abstract: http://www.atsjournals.org/doi/full/10.1164/rccm.200606-824OC#.UrGhL-JHLcY |
| 2007 | Gattringer R, Lagler H, Gattringer KB, Knapp S, Burgmann H, et al. Anakinra in two adolescent female patients suffering from colchicineresistant familial Mediterranean fever: effective but risky. Eur J Clin Invest. 2007, 37:912–914. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/17973784 |
| 2007 | Hantschel O, Rix U, Schmidt U, Burckstummer T, Kneidinger M, Schutze G, Colinge J, Bennett KL, Ellmeier W, Valent P, Superti-Furga G. The Btk tyrosine kinase is a major target of the Bcr-Abl inhibitor dasatinib. Proc Natl Acad Sci USA. 2007, 104:13283–13288. Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1940229/ |
| 2007 | Hartvigsen K, Binder CJ, Hansen LF, Rafia A, Juliano J, et al. A diet-induced hypercholesterolemic murine model to study atherogenesis without obesity and metabolic syndrome. Arterioscl Thromb Vasc Biol. 2007, 27(4):878–85. Abstract: http://atvb.ahajournals.org/content/27/4/878.long |
| 2007 | Kakkad R, Sloane MA, Huang R, Pauler FM, Warczok KE, Melikant B, Radolf M, Martens JHA, Schotta G, Jenuwein T, Barlow DP. Active and Repressive Chromatin Is Interspersed without Spreading in an Imprinted Gene Cluster in the Mammalian Genome. Mol Cell. 2007, 27(3):353–66. Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2847180/ |
| 2007 | Knapp S, Matt U, Leitinger N, van der Poll T. Oxidized phospholipids inhibit phagocytosis and impair outcome in gram-negative sepsis in vivo. J Immunol. 2007, 178:993–1001. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/17202362 |
| 2007 | Knapp S. Innate recognition of bacteria. Expert Rev Clin Immunol. 2007, 3:443–445 (Editorial). Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20477147 |
| 2007 | Kocher T, Superti-Furga G. Mass spectrometry-based functional proteomics: from molecular machines to protein networks. Nat Methods. 2007, 4(10):807–15. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/17901870 |
| 2007 | Orchard S, Salwinski L, Kerrien S, Montecchi- Palazzi L, Oesterheld M, Stumpflen V, Ceol A, Chatr-aryamontri A, Armstrong J, Woollard P, Salama JJ, Moore S, Wojcik J, Bader GD, Vidal M, Cusick ME, Gerstein M, Gavin AC, Superti-Furga G, et al. The minimum information required for reporting a molecular interaction experiment (MIMIx). Nat Biotechnol. 2007, 25(8):894–8. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/17687370 |
| 2007 | Pauler FM, Koerner MV, Barlow DP. Silencing by imprinted noncoding RNAs: is transcription the answer? Trends Genet. 2007, 23(6):284–92. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/17445943 |
| 2007 | Pitzer E, Masselot A, Colinge J. Assessing peptide de novo sequencing algorithms performance on large and diverse data sets. Proteomics 2007, 7:3051–3054. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/17683051 |
| 2007 | Rix U, Hantschel O, Dürnberger G, Remsing Rix LL, Planyavsky M, Fernbach NV, Kaupe I, Bennett KL, Valent P, Colinge J, Köcher T, Superti-Furga G. Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib and dasatinib reveal novel kinase and non-kinase targets. Blood. 2007, 110:4055–4063. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/17720881 |
| 2007 | Schuster C, Fernbach N, Rix U, Superti-Furga G, Holy M, Freissmuth M, Sitte HH, Sexl V. Selective serotonin reuptake inhibitors – A new modality for the treatment of lymphoma/leukaemia? Biochem Pharmacol. 2007, 74(9):1424–35. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/17709099 |